India, March 2 -- image credit- shutterstock

Mumbai-based Emcure Pharmaceuticals has announced the signing of a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio.

The agreement marks a significant step toward expanding patient access to critical therapies in chronic kidney disease (CKD), anemia management, and transplant care across India.

Under the agreement, which will be effective April 1, 2026, Emcure will distribute Roche's established and globally recognised brands in the nephrology and transplant segment in India.

The agreement includes the following brands:

Emcure is a market leader in anemia management, and together with its subsidiaries, has a strong presence across ne...